详情页 - 首都医科大学附属北京同仁医院知识库

当前位置：首页 > 详情页

Downregulation of circulating exosomal miR-638 predicts poor prognosis in colon cancer patients

5| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Weifang Med Univ, Dept Gastrointestinal & Anal Dis Surg, Affiliated Hosp, Weifang, Peoples R China [2]Peoples Hosp Zoucheng, Dept Outpatient, Zoucheng, Peoples R China [3]Xuzhou Med Univ, Affiliated Huaian Hosp, Dept Gen Surg, Div Gastrointestinal Surg, Huaian, Peoples R China [4]Second Peoples Hosp Huaian, Huaian, Peoples R China [5]Weifang Med Univ, Clin Med Coll, Funct Lab, Weifang, Peoples R China [6]Nanjing Med Univ, Affiliated Hosp 1, Dept Image, Nanjing, Jiangsu, Peoples R China [7]Shanghai Jiao Tong Univ, Sch Med, Dept Gastroenterol, Shanghai Tongren Hosp, Shanghai, Peoples R China [8]Hongze Dist Peoples Hosp, Dept Gen Surg, Hongze, Peoples R China

出处：

DOI：

关键词： colon cancer exosomes microRNA-638 prognosis

摘要：

Exosome-encapsulated microRNAs have been recognized as novel and stable biomarkers for cancer. However, little is known about the role of exosomal microRNAs in colon cancer. In the present study, we investigated the expression of serous exosomal microRNA-638 (miR-638) and its prognostic effect in patients with colon cancer. Serous exosomal samples were assayed by quantitative real-time PCR. Kaplan-Meier analysis was adopted to determine the overall survival (OS) and disease-free survival (DFS) of colon cancer patients. Cox regression analysis was applied to assess the potential association between serous exosomal miR-638 and clinicopathological factors of colon cancer patients. MiR-638 was significantly reduced in serum exosomes of colon cancer patients compared with healthy controls. Decreased level of serous exosomal miR-638 was more significant in colon cancer patients at later TNM stage or with liver metastasis. Kaplan-Meier analysis showed that colon cancer patients with reduced level of serous exosomal miR-638 had poor OS and DFS. In addition, the Cox regression analysis suggested serous exosomal miR-638 was a prognostic factor for colon cancer independent of TNM stage and liver metastasis. In conclusion, serous exosomal miR-638 is a useful biomarker for the prediction of colon cancer prognosis.

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2016]版：

大类 | 1 区

医学

小类 | 2 区细胞生物学 2 区肿瘤学

最新[2025]版：

无

JCR分区：

出版当年[2015]版：

Q1 CELL BIOLOGY Q1 ONCOLOGY

最新[2023]版：

无

影响因子： 0 最新[2023版] 0 最新五年平均 5.008 出版当年[2015版] 5.415 出版当年五年平均 6.359 出版前一年[2014版] 5.168 出版后一年[2016版]

第一作者：

第一作者机构： [1]Weifang Med Univ, Dept Gastrointestinal & Anal Dis Surg, Affiliated Hosp, Weifang, Peoples R China

共同第一作者：

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]人结肠癌来源的间充质干细胞通过分泌外泌体促进结肠癌发生发展的机制研究 [2]Exosomal miR-30a and miR-222 derived from colon cancer mesenchymal stem cells promote the tumorigenicity of colon cancer through targeting MIA3 [3]Clinical significance of urothelial carcinoma associated 1 in colon cancer [4]Genomic and immunological features of microsatellite instability in colon cancer [5]AL360181.1 promotes proliferation and invasion in colon cancer and is one of ten m6A-related lncRNAs that predict overall survival [6]Down-regulation of liver-intestine cadherin enhances noscapine-induced apoptosis in human colon cancer cells [7]Development and Clinical Validation of a Novel 4-Gene Prognostic Signature Predicting Survival in Colorectal Cancer [8]Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer [9]Targeting LncRNA EPIC1 to inhibit human colon cancer cell progression [10]Targeting LncRNA EPIC1 to inhibit human colon cancer cell progression.